Hardman & Co

Collagen Solutions Engineering towards CE Mark

Collagen Solutions Plc (LON:COS) is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, research, and regenerative medicine. A number of investment initiatives have

Hardman & Co

Cashflow accounting – The need for consistency

According to the US Securities and Exchange Commission, “Cashflow statements report a company’s inflows and outflows of cash”. This is such a simple and obvious statement. Unfortunately, the failure of

Hardman & Co

Oxford BioMedica plc New era for cell and gene therapies

Oxford Biomedica plc (LON:OXB) is a specialist advanced therapy viral-vector biopharmaceutical company. It offers vector manufacturing and development services, whilst retaining proprietary drug candidates. OXB will also receive royalties on

Hardman & Co

Diurnal Group Plc Ready to press the button

Diurnal Group Plc (LON:DNL) is a clinical stage specialty pharmaceutical company focused on diseases of the endocrine system. Its two lead candidates are targeted at rare diseases with unmet medical

Hardman & Co

1pm plc Financing powerhouse: A lunchtime treat

1pm Plc (LON:OPM) offers a unique exposure to the attractive UK, non-bank, SME financing market. We believe it can deliver superior growth from: (i) focussed business units delivering high service

Hardman & Co

PPHE Hotel Group Ltd Strong results spark upgrades

PPHE Hotel Group Ltd (LON:PPH) reported interim results which were higher than our expectations and we are modestly increasing our forecasts for this year and next. Current profitability is constrained

Hardman & Co

ValiRx Plc GeneICE and VAL101 progress

ValiRx Plc (LON:VAL) is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of cancer, associated biomarkers and companion diagnostics. The company’s two leading assets are

Diversified Energy Company plc
Diversified Energy CEO Rusty Hutson discusses the Maverick Natural Resources acquisition and its impact on growth, margins, and sustainability goals.
Cerillion
In an exclusive interview with DirectorsTalk, Cerillion plc CEO Louis Hall discusses the $11.4 million telecom contract and its impact on the company's growth strategy.
Pan African Resources
Discover the success behind Pan African Resources plc and its outperformance as discussed by Gervais Williams, Co-Fund Manager of Diverse Income Trust plc.
One Health Group plc
In an exclusive interview, One Health Group plc CEO Adam Binns discusses the company's partnership with the NHS, operational growth, and future plans.
Ilika plc
In an exclusive interview, Ilika plc CEO Graeme Purdy discusses progress with Stereax & Goliath, exciting technical milestones, and competition with peers.
Arbuthnot Banking Group plc
Gervais Williams discusses Arbuthnot Banking Group plc's success and potential growth in an exclusive interview with DirectorsTalk.
Discover the latest trends in commercial real estate investment, from shifting market landscapes to emerging opportunities in private credit financing.
Volta Finance
Discover the allure of Collateralized Loan Obligations (CLOs) and how they offer high yields and structured returns to savvy investors in today's market.
Fidelity China Special Situations
China's AI sector is booming thanks to DeepSeek's breakthrough, attracting investment and reshaping the tech rivalry with the U.S. Learn more here.
Fidelity Special Values
The British Pound is gaining momentum against the US Dollar, with potential for a test of the 2025 high. Trade tensions and central banks drive volatility.
Fidelity European Trust
European markets saw a lift driven by key earnings reports, with notable movements in sectors like automobiles and financial services. Read more here.
Beeks Financial Cloud Group Plc secures Nasdaq as the latest customer for its Exchange Cloud service, solidifying its leadership in low-latency solutions.
Agronomics Limited (LON:ANIC) shapes the future of sustainable food production with strategic investments in cellular agriculture. Cavendish report highlights its progress in 2024.
SAE Renewables (LON:SAE) advances energy ambitions with £1.3M payment for Uskmouth BESS project. Analyst sees positive impact on future projects.
hVIVO plc
hVIVO plc achieves milestone with £3.2 million hLAB contract, showcasing growth in laboratory services. Read about the company's latest achievement here.
Greggs
Greggs plc (LON:GRG) shines in tough market conditions, delivering solid FY24 results with revenue of £2,014 million and strong growth.